Antimicrobial Resistance Action Fund

Big pharma, battling COVID-19, looks to 'buy time' on another health crisis: superbugs
BioPharma Dive
Thu, 07/9/20 - 10:24 pm
antibiotics
superbugs
Big Pharma
Eli Lilly
Antimicrobial Resistance Action Fund